col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


27 Results       Page 1

 [1] 
AVES Publishing Co.: European Journal of Rheumatology
  original article Date Title Authors   All Authors
1 [GO] 2026―Mar―11 Unmasking Eosinophilic Granulomatosis with Polyangiitis: A Case of Rapid-Onset Myositis Following COVID-19 Booster in an Eosinophilic Asthma Patient Anisha Memdani, Vishal Busa, Samhitha Avula, Alexis Ford, Joseph Nesheiwat
2 [GO] 2025―Jul―29 Coronavirus Disease 2019 Outcomes in Amyloid A Protein Amyloidosis Secondary to Rheumatic Conditions and Signs of Post- Coronavirus Disease 2019 Proteinuria Progression Serdar Can Güven, Abdulsamet Erden, Hamit Küçük, Hakan Apaydın, Bünyamin Polat, Rıza Can Kardaş, et al. (+6)
3 [GO] 2025―Jun―05 First Report of the Immunogenicity of an Inactivated SARS-CoV-2 (COVID-19) Vaccine in Iranian Patients with Autoimmune Diseases Parmida Aminzadeh, Ava Hashempour, Shahab Falahi, Farimah Safari, Maryam Feili, Azra Kenarkoohi
4 [GO] 2025―Apr―29 The Assessment of Perceived Stress, Anxiety, Depression, Insomnia, Sleep Quality, and Drug Adherence in Patients with Systemic Lupus Erythematosus During the COVID-19 Pandemic Kardelen Gokmen, Dilek Barutcu Atas, Murat Tugcu, Arzu Velioglu, Hakki Arikan, Fatma Alibaz Oner, et al. (+3)
5 [GO] 2025―Apr―17 Can the Early Warning Score (ANDC) Predict Tocilizumab Efficacy in Patients with COVID-19 Cytokine Storm? Özlem Kılıç, Duygu Tecer, Mehmet Nur Kaya, Muhammet Çınar, Sedat Yılmaz
6 [GO] 2024―Nov―28 The COVID-19 Pandemic Heightens Interest in Cytokine Storm Disease and Advances in Machine Learning Diagnosis, Telemedicine, and Primordial Prevention of Rheumatic Diseases Tomohiro Koga, Shin-Ya Kawashiri, Fumiaki Nonaka, Yoshika Tsuji, Mami Tamai, Atsushi Kawakami
7 [GO] 2023―Oct―26 Coronavirus Disease 2019 in Rheumatic Patients with Inflammatory Disorders: A Descriptive Study from a High Infection Incidence Region of Northern Spain
8 [GO] 2023―Jan―17 The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database Nilufer Alpay Kanitez, Sedat Kiraz, Ediz Dalkilic, Gezmis Kimyon, Ridvan Mercan, Omer Karadag, et al. (+17)
9 [GO] 2022―Dec―08 Systemic Lupus Erythematosus Following COVID-19 Vaccination Anna Farazilah Mohd Salleh, Cheng Lay Teh, Sharifah Aishah Wan Mohamad Akbar, Yaw Kiet Cheong, Benjamin Sachdev Manjit Singh, Kar Hoo Lee, et al. (+3)
10 [GO] 2022―Jan―31 Early impacts of the COVID-19 pandemic on children with pediatric rheumatic diseases Jonathan S. Hausmann, Kevin Kennedy, Salman Surangiwala, Maggie J. Larche, Rashmi Sinha, Karen Durrant, et al. (+8)
11 [GO] 2022―Jan―31 Engaging trainees within the virtual classroom: Teaching strategies for rheumatologists in a pandemic Stefanie D. Wade
12 [GO] 2022―Jan―24 What are the main factors affecting the outcome of tocilizumab therapy in COVID-19-induced cytokine release syndrome? Cansu Akleylek, Seray Gizem Gür, Ibrahim Halil Sever, Safiye Koçulu Demir, Esin Çevik, Egemen Eken, et al. (+3)
13 [GO] 2021―Dec―31 Physical activity and psychosomatic status in patients with Behçet’s disease during coronavirus disease pandemic Songul Baglan Yentur, Furkan Bilek, Süleyman Serdar Koca
14 [GO] 2020―Oct―08 Revisiting cardiac safety of hydroxychloroquine in rheumatological diseases during COVID-19 era: Facts and myths Shivraj Padiyar, Debashish Danda
15 [GO] 2020―Jul―23 Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemic Eric J. Gapud, Andreas Kronbichler, Philipp Gauckler, Duvuru Geetha
16 [GO] 2020―Jul―23 Conducting research in a pandemic: The power of social media Jonathan S. Hausmann, Paul Sufka, Suleman Bhana, Jean W. Liew, Pedro M. Machado, Zachary S. Wallace, et al. (+5)
17 [GO] 2020―Jul―20 Coronavirus 2019 outbreak pathogenesis: Why China and Italy? Anat Achiron, Mathilda Mandel, Yehuda Sheonefeld
18 [GO] 2020―May―22 A perspective on modern advances for COVID-19 (SARS-CoV-2) therapeutics Amit Lakhanpal, Ernest Brahn
19 [GO] 2020―May―18 Hydroxychloroquine against COVID-19: A critical appraisal of the existing evidence Konstantinos Tselios, Panagiotis Skendros
20 [GO] 2020―May―13 Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation Pierre Miossec
21 [GO] 2020―May―07 The emerging role of lung ultrasound in COVID-19 pneumonia Gemma Lepri, Martina Orlandi, Chiara Lazzeri, Cosimo Bruni, Michael Hughes, Manuela Bonizzoli, et al. (+3)
22 [GO] 2020―Apr―17 Facing the SARS-CoV-2 (COVID-19) outbreak with IL-6R antagonists Hèctor Corominas, Ivan Castellví, Pere Domingo, Jordi Casademont
23 [GO] 2020―Apr―15 The impact of COVID-19 on rheumatology clinical practice and university teaching in Sydney, Australia Ken Cai, Jianna He, Peter KK Wong, Nicholas Manolios
24 [GO] 2020―Apr―15 Egypt’s groundwork blessing during the COVID-19 pandemic curse: Rheumatologic experience Tamer A. Gheita, Sanaa A. Kenawy
25 [GO] 2020―Apr―10 Being a rheumatologist and a patient with a rheumatic disease today: A perspective at the time of COVID-19 Carlo Perricone, Roberto Gerli
26 [GO] 2020―Apr―10 Management strategies for patients with autoimmune diseases during the COVID-19 pandemic: A perspective from China Yu Liu, Christopher Chang, Qianjin Lu
27 [GO] 2020―Apr―08 Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus Amr H. Sawalha, Susan Manzi
 [1] 

27 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.005 sec